IBIO, INC.

Profile

Company Names

IBIO, INC.

Addresses

11750 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO, CA 92121

8800 HSC PARKWAY, BRYAN, TX 77807

600 MADISON AVENUE, SUITE 1601, NEW YORK, NY 10022

9 INNOVATION WAY, SUITE 100, NEWARK, DE 19711

Phone Numbers

(979) 446-0027
(302) 355-0650
302 355-0650

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$64,380,745.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2026-01-08 
$25,985,431.00 
$25,985,431.00 
$0.00 
 
6
2025-04-29 
$11,084,569.00 
$11,084,569.00 
$0.00 
 
5
2024-03-26 
$15,068,745.00 
$15,068,745.00 
$0.00 
Equity 
4
2023-08-04 
$0.00 
$10,000,000.00 
$10,000,000.00 
Equity 
3
2016-01-25 
$2,177,000.00 
$2,177,000.00 
$0.00 
Equity 
2
2010-10-27 
$7,065,000.00 
$8,000,000.00 
$935,000.00 
Equity 
1
2009-09-10 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LINDA 
 
ARMSTRONG 
DIRECTOR
MARC 
 
BANJAK 
EXECUTIVE OFFICER
PAMELA 
 
BASSETT 
DIRECTOR
MARTIN 
 
BRENNER 
EXECUTIVE OFFICER
MARTIN 
A. 
BRENNER 
EXECUTIVE OFFICER, DIRECTOR
GLENN 
 
CHANG 
DIRECTOR
FELIPE 
 
DURAN 
EXECUTIVE OFFICER
ARTHUR 
 
ELLIOTT 
DIRECTOR
SEYMOUR 
 
FLUG 
DIRECTOR
MARK 
 
GIANNONE 
EXECUTIVE OFFICER
JAMES 
T. 
HILL 
DIRECTOR
ROBERT 
 
KAY 
EXECUTIVE OFFICER, DIRECTOR
ALEXANDRA 
 
KROPOTOVA 
DIRECTOR
ALEXANDRA 
 
KROPTOVA 
DIRECTOR
FREDERICK 
 
LARCOMBE 
EXECUTIVE OFFICER
JOHN 
 
MCKEY 
DIRECTOR
JOHN 
MCKEY 
DIRECTOR
ANTONIO 
 
PARADA 
DIRECTOR
PHILIP 
 
RUSSELL 
DIRECTOR
PHILIP 
K. 
RUSSELL 
DIRECTOR
TERENCE 
 
RYAN 
EXECUTIVE OFFICER
GEOFFREY 
 
SCHILD 
EXECUTIVE OFFICER
EVERT 
 
SCHIMMELPENNINK 
DIRECTOR
GARY 
 
SENDE 
DIRECTOR
GARY 
 
SENDER 
DIRECTOR
EVERT 
 
SHIMMELPENNINK 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-01-08 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-04-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-26 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-08-04 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2016-01-25 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-10-27 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
NONE
NONE
LIFESCI CAPITAL LLC
NONE
NONE
OPPENHEIMER + CO. INC.
NONE
NONE
CHARDAN CAPITAL MARKETS LLC
NONE
NONE
NOBLE INTERNATIONAL INVESTMENTS, INC.
NONE
NONE
NOBLE FINANCIAL CAPITAL MARKETS